<it>Actinobaculum schaalii</it> an emerging pediatric pathogen?

<p>Abstract</p> <p>Background</p> <p><it>Actinobaculum schaalii</it> was first described as a causative agent for human infection in 1997. Since then it has mainly been reported causing urinary tract infections (UTI) in elderly individuals with underlying ur...

Full description

Bibliographic Details
Main Authors: Zimmermann Petra, Berlinger Livia, Liniger Benjamin, Grunt Sebastian, Agyeman Philipp, Ritz Nicole
Format: Article
Language:English
Published: BMC 2012-08-01
Series:BMC Infectious Diseases
Subjects:
Online Access:http://www.biomedcentral.com/1471-2334/12/201
_version_ 1818148068342628352
author Zimmermann Petra
Berlinger Livia
Liniger Benjamin
Grunt Sebastian
Agyeman Philipp
Ritz Nicole
author_facet Zimmermann Petra
Berlinger Livia
Liniger Benjamin
Grunt Sebastian
Agyeman Philipp
Ritz Nicole
author_sort Zimmermann Petra
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p><it>Actinobaculum schaalii</it> was first described as a causative agent for human infection in 1997. Since then it has mainly been reported causing urinary tract infections (UTI) in elderly individuals with underlying urological diseases. Isolation and identification is challenging and often needs molecular techniques. <it>A. schaalii</it> is increasingly reported as a cause of infection in humans, however data in children is very limited.</p> <p>Case presentation</p> <p>We present the case of an 8-month-old Caucasian boy suffering from myelomeningocele and neurogenic bladder who presented with a UTI. An ultrasound of the urinary tract was unremarkable. Urinalysis and microscopy showed an elevated leukocyte esterase test, pyuria and a high number of bacteria. Empiric treatment with oral co-trimoxazole was started.</p> <p>Growth of small colonies of Gram-positive rods was observed after 48 h. Sequencing of the 16S rRNA gene confirmed an <it>A. schaalii</it> infection 9 days later. Treatment was changed to oral amoxicillin for 14 days. On follow-up urinalysis was normal and urine cultures were negative.</p> <p>Conclusions</p> <p><it>A.schaalii</it> is an emerging pathogen in adults and children. Colonization and subsequent infection seem to be influenced by the age of the patient. In young children with high suspicion of UTI who use diapers or in children who have known abnormalities of their urogenital tract, infection with <it>A. schaalii</it> should be considered and empiric antimicrobial therapy chosen accordingly.</p>
first_indexed 2024-12-11T12:45:16Z
format Article
id doaj.art-1f93fbdbfb244c31a9546b1749b6384f
institution Directory Open Access Journal
issn 1471-2334
language English
last_indexed 2024-12-11T12:45:16Z
publishDate 2012-08-01
publisher BMC
record_format Article
series BMC Infectious Diseases
spelling doaj.art-1f93fbdbfb244c31a9546b1749b6384f2022-12-22T01:06:50ZengBMCBMC Infectious Diseases1471-23342012-08-0112120110.1186/1471-2334-12-201<it>Actinobaculum schaalii</it> an emerging pediatric pathogen?Zimmermann PetraBerlinger LiviaLiniger BenjaminGrunt SebastianAgyeman PhilippRitz Nicole<p>Abstract</p> <p>Background</p> <p><it>Actinobaculum schaalii</it> was first described as a causative agent for human infection in 1997. Since then it has mainly been reported causing urinary tract infections (UTI) in elderly individuals with underlying urological diseases. Isolation and identification is challenging and often needs molecular techniques. <it>A. schaalii</it> is increasingly reported as a cause of infection in humans, however data in children is very limited.</p> <p>Case presentation</p> <p>We present the case of an 8-month-old Caucasian boy suffering from myelomeningocele and neurogenic bladder who presented with a UTI. An ultrasound of the urinary tract was unremarkable. Urinalysis and microscopy showed an elevated leukocyte esterase test, pyuria and a high number of bacteria. Empiric treatment with oral co-trimoxazole was started.</p> <p>Growth of small colonies of Gram-positive rods was observed after 48 h. Sequencing of the 16S rRNA gene confirmed an <it>A. schaalii</it> infection 9 days later. Treatment was changed to oral amoxicillin for 14 days. On follow-up urinalysis was normal and urine cultures were negative.</p> <p>Conclusions</p> <p><it>A.schaalii</it> is an emerging pathogen in adults and children. Colonization and subsequent infection seem to be influenced by the age of the patient. In young children with high suspicion of UTI who use diapers or in children who have known abnormalities of their urogenital tract, infection with <it>A. schaalii</it> should be considered and empiric antimicrobial therapy chosen accordingly.</p>http://www.biomedcentral.com/1471-2334/12/201<it>Actinobaculum schaalii</it>ChildrenEmerging infectionUrinary tract infectionGram-positiveAntimicrobial susceptibility
spellingShingle Zimmermann Petra
Berlinger Livia
Liniger Benjamin
Grunt Sebastian
Agyeman Philipp
Ritz Nicole
<it>Actinobaculum schaalii</it> an emerging pediatric pathogen?
BMC Infectious Diseases
<it>Actinobaculum schaalii</it>
Children
Emerging infection
Urinary tract infection
Gram-positive
Antimicrobial susceptibility
title <it>Actinobaculum schaalii</it> an emerging pediatric pathogen?
title_full <it>Actinobaculum schaalii</it> an emerging pediatric pathogen?
title_fullStr <it>Actinobaculum schaalii</it> an emerging pediatric pathogen?
title_full_unstemmed <it>Actinobaculum schaalii</it> an emerging pediatric pathogen?
title_short <it>Actinobaculum schaalii</it> an emerging pediatric pathogen?
title_sort it actinobaculum schaalii it an emerging pediatric pathogen
topic <it>Actinobaculum schaalii</it>
Children
Emerging infection
Urinary tract infection
Gram-positive
Antimicrobial susceptibility
url http://www.biomedcentral.com/1471-2334/12/201
work_keys_str_mv AT zimmermannpetra itactinobaculumschaaliiitanemergingpediatricpathogen
AT berlingerlivia itactinobaculumschaaliiitanemergingpediatricpathogen
AT linigerbenjamin itactinobaculumschaaliiitanemergingpediatricpathogen
AT gruntsebastian itactinobaculumschaaliiitanemergingpediatricpathogen
AT agyemanphilipp itactinobaculumschaaliiitanemergingpediatricpathogen
AT ritznicole itactinobaculumschaaliiitanemergingpediatricpathogen